This great investigation The Cleveland Plain Dealer illustrates how the badly named Fast Track designation many drug companies brag about often doesn't result in faster drugs or better outcomes, either for long-term investors or patients. Found via Pharmalot.
My colleague Robert Langreth has a fantastic story about the cutting edge of vaccine development, including this striking story of a researcher who volunteered to be part of a test for a new malaria vaccine.
Newest Clips
see Newest Clips
2
Latest Pops
Latest Comments
Most Pops
Tags
Print
Save
Turn on live update